Skip to Main Content

Author Details

Robert A Holt
BC Cancer Research Institute
1996
156
64
PMIDPaper TitleJournal TitlePublished Year
36634619Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes.Cell Host Microbe2023
36964503Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies' MinION device.BMC Bioinformatics2023
36634619Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes.Cell Host Microbe2023
36982943Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study.Int J Mol Sci2023
36982943Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study.Int J Mol Sci2023
36964503Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies' MinION device.BMC Bioinformatics2023
34995318Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.PLoS One2022
35755944Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus.Mol Ther Methods Clin Dev2022
36601119CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.Front Immunol2022
34995318Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.PLoS One2022
35755944Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus.Mol Ther Methods Clin Dev2022
36601119CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.Front Immunol2022
33020056Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.Clin Cancer Res2021
33741670Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial.BMJ Open2021
33766105Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.Trials2021
33020056Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.Clin Cancer Res2021
34700376Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.mBio2021
34931022Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.NPJ Precis Oncol2021
34583126Improved resolution of phenotypic subsets in human T-ALL by incorporation of RNA-seq based developmental profiling.Leuk Res2021
33741670Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial.BMJ Open2021
33766105Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.Trials2021
34931022Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.NPJ Precis Oncol2021
34700376Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.mBio2021
34583126Improved resolution of phenotypic subsets in human T-ALL by incorporation of RNA-seq based developmental profiling.Leuk Res2021
32128343A Rapid and Sensitive Nucleic Acid Amplification Technique for <i>Mycoplasma</i> Screening of Cell Therapy Products.Mol Ther Methods Clin Dev2020
32128343A Rapid and Sensitive Nucleic Acid Amplification Technique for <i>Mycoplasma</i> Screening of Cell Therapy Products.Mol Ther Methods Clin Dev2020
31837431Sample Tracking Using Unique Sequence Controls.J Mol Diagn2020
32338916Complementary Methods for de Novo Monoclonal Antibody Sequencing to Achieve Complete Sequence Coverage.J Proteome Res2020
31661053A survey of <i>Fusobacterium nucleatum</i> genes modulated by host cell infection.Microb Genom2020
33262762Tumor Infiltrating Effector Memory Antigen-Specific CD8<sup>+</sup> T Cells Predict Response to Immune Checkpoint Therapy.Front Immunol2020
32688454Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study.Br J Haematol2020
33072399Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.Res Involv Engagem2020
33163002Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.Front Immunol2020
35121966Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.Nat Cancer2020
35121966Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.Nat Cancer2020
31837431Sample Tracking Using Unique Sequence Controls.J Mol Diagn2020
31661053A survey of <i>Fusobacterium nucleatum</i> genes modulated by host cell infection.Microb Genom2020
33163002Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.Front Immunol2020
33072399Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.Res Involv Engagem2020
33262762Tumor Infiltrating Effector Memory Antigen-Specific CD8<sup>+</sup> T Cells Predict Response to Immune Checkpoint Therapy.Front Immunol2020
32688454Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study.Br J Haematol2020
32338916Complementary Methods for de Novo Monoclonal Antibody Sequencing to Achieve Complete Sequence Coverage.J Proteome Res2020
30418619Sources of erroneous sequences and artifact chimeric reads in next generation sequencing of genomic DNA from formalin-fixed paraffin-embedded samples.Nucleic Acids Res2019
31591401Rapid selection and identification of functional CD8<sup>+</sup> T cell epitopes from large peptide-coding libraries.Nat Commun2019
32002298Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma.Oncoimmunology2019
30418619Sources of erroneous sequences and artifact chimeric reads in next generation sequencing of genomic DNA from formalin-fixed paraffin-embedded samples.Nucleic Acids Res2019
30744412A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral blood.Biotechniques2019
31433971The Immune Landscape of Cancer.Immunity2019
30948292Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis.Transfus Med Rev2019
30833417Base excision repair deficiency signatures implicate germline and somatic <i>MUTYH</i> aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis.Cold Spring Harb Mol Case Stud2019
  • 1 - 50 of 312

Recommended Authors

Melissa L Smith
University of Louisville
Career Start Year 2016
Number of shared co-authors 9
Marta Gut
Universitat de Barcelona (UB)
Career Start Year 2010
Number of shared co-authors 42
Joseph B Hiatt
Fred Hutchinson Cancer Center
Career Start Year 2009
Number of shared co-authors 15
Cameron Ross MacPherson
Rigshospitalet, Copenhagen University Hospital
Career Start Year 2008
Number of shared co-authors 2
Raoul J P Bonnal
National Institute for Molecular Genetics "Romeo ed Enrica Invernizzi"
Career Start Year 2006
Number of shared co-authors 2
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Career Start Year 2006
Number of shared co-authors 27
Robert Sebra
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 25
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Career Start Year 2004
Number of shared co-authors 37
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 61
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Career Start Year 2002
Number of shared co-authors 4
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 18
Sophia Derdak
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 17
Anna C M Salim
Instituto Rene Rachou
Career Start Year 2001
Number of shared co-authors 1
Jason F Kreisberg
University of California San Diego
Career Start Year 2000
Number of shared co-authors 5
Kirsten McLay
Inivata Ltd.
Career Start Year 1999
Number of shared co-authors 76
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 16
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 17
David R Powell
Biomedicine Discovery Institute, Monash University
Career Start Year 1998
Number of shared co-authors 1
Vincent Magrini
The Ohio State University
Career Start Year 1997
Number of shared co-authors 63
Sean McGrath
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 39
Jared C Roach
Institute for Systems Biology
Career Start Year 1995
Number of shared co-authors 15
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 5
Joseph L DeRisi
University of California San Francisco
Career Start Year 1994
Number of shared co-authors 14
Joakim Lundeberg
KTH Royal Institute of Technology
Career Start Year 1990
Number of shared co-authors 4
Helena Persson
Lund University Cancer Centre
Career Start Year 1989
Number of shared co-authors 8
Andreas Gnirke
The Center for Genome Architecture, Baylor College of Medicine
Career Start Year 1986
Number of shared co-authors 89
Roderick V Jensen
Virginia Tech
Career Start Year 1985
Number of shared co-authors 8
Richard H Scheuermann
J. Craig Venter Institute
Career Start Year 1983
Number of shared co-authors 18
Stephan Beck
UCL Cancer Institute, University College London
Career Start Year 1983
Number of shared co-authors 89
George M Church
Harvard Medical School
Career Start Year 1977
Number of shared co-authors 26

Collaborators

Steven J M Jones
University of British Columbia
Co-authored papers 61
Marco A Marra
University of British Columbia
Co-authored papers 54
Richard A Moore
Co-authored papers 34
Scott D Brown
BC Cancer Research Institute
Co-authored papers 19
Andrew J Mungall
Co-authored papers 19
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 19
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 18
Martin Hirst
University of British Columbia
Co-authored papers 16
Yaron S Butterfield
Brain Tumour Foundation of Canada
Co-authored papers 13
Michael Mayo
Co-authored papers 10
Ryan D Morin
Simon Fraser University
Co-authored papers 10
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 9
Yussanne Ma
Co-authored papers 8
Eric Chuah
Co-authored papers 8
Angela Tam
Co-authored papers 7
Miruna Balasundaram
Co-authored papers 7
Wyeth W Wasserman
BC Children's Hospital Research Institute, University of British Columbia
Co-authored papers 7
Granger G Sutton
J. Craig Venter Institute
Co-authored papers 7
Dan Goldowitz
University of British Columbia
Co-authored papers 6
Janessa Laskin
Co-authored papers 6
Richard A Gibbs
Baylor College of Medicine
Co-authored papers 6
Noreen Dhalla
Co-authored papers 6
Martin Krzywinski
BC Cancer Research Center
Co-authored papers 6
Adrian Ally
Co-authored papers 6
Malachi Griffith
Washington University
Co-authored papers 6
Cheryl L Kraft
Co-authored papers 6
Zhongwu Lai
Oncology R&D
Co-authored papers 5
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 5
Cynthia Andrews-Pfannkoch
Mayo Clinic
Co-authored papers 5
Mark Yandell
University of Utah
Co-authored papers 5
Release 1.2